Government ❯ Health Policy

Regulatory Agencies

FDA Anvisa ANMAT Drug Regulation Drug Approval Health Recommendations Health Regulations Cofepris Food and Drug Administration ANVISA Centers for Disease Control and Prevention Ministry of Health Drug Safety Consumer Protection Food Safety Drug Safety Regulations Sanitary Surveillance Medicines Regulation Drug Control Pharmaceutical Oversight Centers for Medicare & Medicaid Services State Health Departments Drug Approval Process Food Regulation Clinical Trials Judicial Decisions Health Inspections Public Health Health Canada MHRA Law Enforcement Medical Guidelines Food Safety Regulations Medical Oversight National Toxicology Program Health Agencies Inspection Protocols Centers for Medicare and Medicaid Services Product Liability Pharmaceutical Industry Public Health Leadership CDC Recommendations WHO Medicines and Healthcare Products CDC MHRA Actions National Institute of Medicines Instituto Nacional de Medicamentos AHPRA Pharmacy Regulation

HHS Begins Decertification of Network for Hope Over Patient-Safety Failures

Federal reviewers found serious clinical lapses in nearly 30% of examined cases, prompting HHS to start formal decertification.

FDA Scientists Say Evidence Lacks for Allowing Seven Popular Peptides in Compounding

HHS Confirms FDA Halted Studies Finding COVID and Shingles Vaccines Safe

Bhattacharya Poised to Lead CDC as Acting Director After Year of RFK Jr. Upheaval

FDA Rejects Filing of Moderna’s mRNA Flu Vaccine Over Comparator Dispute

HHS Opens Review of Cellphone Radiation Risks as FDA Pulls Old Safety Pages

Kennedy Appoints Two OB-GYNs to CDC Vaccine Panel, Extending Overhaul of ACIP

FDA Opens Safety Review of Infant RSV Antibody Drugs Beyfortus and Enflonsia

FDA Installs Tracy Beth Hoeg as Acting CDER Director as Pazdur Files Retirement

CMS Finalizes 2026 Medicare Physician Fee Schedule With Efficiency Cuts and Two‑Tier Rates

Kennedy Says Evidence Is Not Sufficient to Link Tylenol to Autism

Med Safety App Boosts Adverse Drug Reaction Reports by 73% in Uganda Trial

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk